- Last edited on April 30, 2020
Differences
This shows you the differences between two versions of the page.
|
meds:dopamine-agonists:bromocriptine [on April 25, 2020] |
meds:dopamine-agonists:bromocriptine [on February 18, 2022] (current) psychdb [Primer] |
||
|---|---|---|---|
| Line 2: | Line 2: | ||
| {{INLINETOC}} | {{INLINETOC}} | ||
| ===== Primer ===== | ===== Primer ===== | ||
| + | **Bromocriptine** is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and type 2 diabetes | ||
| + | |||
| + | |||
| + | ===== Adverse Events ===== | ||
| + | ==== Impulse-Control Disorders (ICDs) ==== | ||
| + | {{page>geri:parkinsons#impulse-control-disorders-icd&nouser&noheader&nodate&nofooter}} | ||
| + | |||